Acerand Therapeutics Doses First Patient in Phase I Trial of Novel CYP11A1 Inhibitor ACE-232 for Prostate Cancer

Acerand Therapeutics, a clinical-stage biotech company focusing on the discovery and development of innovative small-molecule therapies in oncology, toda...

June 05, 2025 | Thursday | News
Conduit Pharmaceuticals and Manoira Partner to Advance Cross-Species Glucokinase Activator Programs in $15B Animal Health Market

Collaboration leverages cutting-edge reformulation expertise to generate cross-species insights, fast-track human clinical programs, and seeks to captu...

June 05, 2025 | Thursday | News
Trethera Secures Exclusive Worldwide License From UCLA to Expand TRE-515 Patent Protection

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune d...

June 04, 2025 | Wednesday | News
BioAge Labs Expands Obesity Pipeline With APJ Agonist Advances and JiKang Therapeutics Option Deal

BioAge Labs, Inc. ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by t...

June 04, 2025 | Wednesday | News
Esperion Reaches Patent Litigation Settlement With Hetero USA Over NEXLETOL

Esperion  announced that it has entered into a settlement agreement with Hetero USA, Inc. and its affiliates Hetero Labs Limited, Hetero Labs Limite...

June 04, 2025 | Wednesday | News
CERo Therapeutics Expands Global Patent Portfolio With New U.S. and European Grants Covering Lead Candidate CER-1236

CERo Therapeutics Holdings, Inc,an innovative immunotherapy company seeking to advance the next generation of  engineered T cell therapeutics that d...

June 03, 2025 | Tuesday | News
Indaptus Therapeutics Doses First Patient in Decoy20 and Tislelizumab Combination Trial for Advanced Solid Tumors

Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical-stage biotechnology company dedicated to developing novel treatments for cancer and viral infectio...

June 03, 2025 | Tuesday | News
Recludix Pharma and Sanofi Advance Oral STAT6 Inhibitor REX-8756 Toward the Clinic for Inflammatory Diseases

Recludix Pharma, a leader in the discovery of inhibitors of challenging targets for inflammatory disease, today announced that the company has nominated ...

June 03, 2025 | Tuesday | News
Curevo Enrolls First Patients in Phase 2 Extension Trial of Shingles Vaccine Amezosvatein

Curevo Vaccine (Curevo), a privately-held clinical-stage biotechnology company dedicated to developing varicella zoster virus (VZV) vaccines with improve...

June 03, 2025 | Tuesday | News
Kura Oncology’s NDA for Ziftomenib in NPM1-Mutant AML Accepted by FDA with Priority Review

Kura Oncology, Inc.  announced the U.S. Food and Drug Administration (FDA) has accepted Kura’s New Drug Application (NDA) seeking full approva...

June 02, 2025 | Monday | News
Medcrypt Launches Intelligence Platform to Transform Medical Device Cybersecurity

Medcrypt, the leading provider of proactive cybersecurity solutions for medical devices, announced today a major milestone in its continued growth, fuele...

May 30, 2025 | Friday | News
Danaher and AstraZeneca Partner to Advance AI-Powered Diagnostics for Precision Medicine

Danaher has entered a partnership with AstraZeneca to scale precision medicine, including developing the next generation of AI-powe...

May 30, 2025 | Friday | News
Alzamend Doses First Patient in Phase II Trial of AL001, Aiming to Transform Lithium Therapy for Neurological Disorders

Topline data expected by year end Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithi...

May 30, 2025 | Friday | News
Candel Therapeutics Secures FDA RMAT Designation for CAN-2409 in Localized Prostate Cancer

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological ...

May 29, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close